Advanced Prostate Cancer: PSMA-Targeted Radioligand Therapies

home / news-network / advanced-prostate-cancer-psma-targeted-radioligand-therapies
Prostate Cancer Disease Complexity and Testing

EP. 1: Prostate Cancer Disease Complexity and Testing

July 23rd 2021

Neal Shore, MD, discusses the complexity of prostrate cancer and factors to consider when determining management strategies.

Genotypic and Phenotypic Biomarkers in Prostate Cancer

EP. 2: Genotypic and Phenotypic Biomarkers in Prostate Cancer

July 23rd 2021

A discussion of phenotypic and genotypic biomarkers found in prostate cancer and their implications.

Diagnostic and Therapeutic Applications of PSMA in Prostate Cancer

EP. 3: Diagnostic and Therapeutic Applications of PSMA in Prostate Cancer

July 28th 2021

An overview of the diagnostic and therapeutic applications of PSMA in prostate cancer is presented.

Use of PSMA PET Scans in Advanced Prostate Cancer

EP. 4: Use of PSMA PET Scans in Advanced Prostate Cancer

July 30th 2021

Dr Neal Shore explains the clinical implications of PSMA PET scans in advanced prostate cancer.

The VISION Study of 177Lu-PSMA-617 in mCRPC

EP. 5: The VISION Study of 177Lu-PSMA-617 in mCRPC

August 6th 2021

Results of the phase 3 VISION study of 177Lu-PSMA PET in advanced prostate cancer are described.

Future Directions With PSMA Ligand–Directed Therapies

EP. 6: Future Directions With PSMA Ligand–Directed Therapies

August 6th 2021

Highlights of potential future applications of PSMA ligand–directed therapies in prostate cancer.